An Organometallic Gold(I) Bis-N-Heterocyclic Carbene Complex with Multimodal Activity in Ovarian Cancer Cells

Chemistry. 2020 Dec 1;26(67):15528-15537. doi: 10.1002/chem.202003495. Epub 2020 Nov 3.

Abstract

The organometallic AuI bis-N-heterocyclic carbene complex [Au(9-methylcaffeine-8-ylidene)2 ]+ (AuTMX2 ) was previously shown to selectively and potently stabilise telomeric DNA G-quadruplex (G4) structures. This study sheds light on the molecular reactivity and mode of action of AuTMX2 in the cellular context using mass spectrometry-based methods, including shotgun proteomics in A2780 ovarian cancer cells. In contrast to other metal-based anticancer agents, this organogold compound is less prone to form coordinative bonds with biological nucleophiles and is expected to exert its drug effects mainly by non-covalent interactions. Global protein expression changes of treated cancer cells revealed a multimodal mode of action of AuTMX2 by alterations in the nucleolus, telomeres, actin stress-fibres and stress-responses, which were further supported by pharmacological assays, fluorescence microscopy and cellular accumulation experiments. Proteomic data are available via ProteomeXchange with identifier PXD020560.

Keywords: G-quadruplexes; N-heterocyclic carbenes; cancer; gold complexes; proteomics; telomeres.

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Caffeine / analogs & derivatives
  • Caffeine / chemistry
  • Caffeine / pharmacology
  • Cell Line, Tumor
  • Female
  • Gold* / chemistry
  • Gold* / pharmacology
  • Humans
  • Methane / analogs & derivatives
  • Methane / chemistry
  • Methane / pharmacology
  • Organometallic Compounds* / pharmacology
  • Ovarian Neoplasms* / drug therapy
  • Proteomics

Substances

  • Antineoplastic Agents
  • Organometallic Compounds
  • carbene
  • Caffeine
  • Gold
  • Methane